Kenvue (KVUE) stock
Last close $19.31 on 2026-10-30 (-1.28%) · Sector: Consumer Defensive
Kenvue is a consumer health company best known for everyday brands such as Tylenol pain relievers, Band-Aid bandages, Neosporin first-aid products, Listerine mouthwash, and Aveeno skin care. It makes money by selling these products to retailers and pharmacies and directly to shoppers, so its income depends on people continuing to buy household staples.
Kenvue's last close was $19.31, which is above both its 50-day average (about $18.41) and its 200-day average (about $18.19), signs that the recent price trend is stronger than its longer-term trend. Over the past year the stock returned 15.2% versus 13.0% for the S&P 500, so it beat the broad market. The stock sits 4.1% below its 52-week high of $20.13 and has been more volatile than the market. The facts we have do not include insider trades or how the stock reacted to past earnings reports.
Performance and risk
1-year return +15.2% vs S&P 500 +13.0% · volatility 21.1% (S&P 500 12.6%) · largest drop -13.3% · beta 0.04
KVUE stock research · KVUE options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.